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Background: Indoxyl sulfate (IS), an organic anion uremic toxin, promotes the progression of renal dysfunction.
Some studies have suggested that IS inhibits osteoclast differentiation and suppresses parathyroid hormone
(PTH)-stimulated intracellular cAMP production, decreases PTH receptor expression, and induces oxidative stress in
primary mouse calvaria osteoblast cell culture. However, the direct effects of IS on osteoblast apoptosis have not
been fully evaluated. Hence, we investigated whether IS acts as a bone toxin by studying whether IS induces
apoptosis and inhibits differentiation in the cultured osteoblast cell line MC3T3-E1.
Methods: We assessed the direct effect of IS on osteoblast differentiation and apoptosis in the MC3T3-E1 cell line.
We examined caspase-3/7 activity, apoptosis-related proteins, free radical production, alkaline phosphatase activity,
and mRNA expression of type 1 collagen and osteonectin. Furthermore, we investigated the uptake of IS via organic
anion transport (OAT).
Results: We found that IS increased caspase activity and induced apoptosis. Production of free radicals increased
depending on the concentration of IS. Furthermore, IS inhibited the expression of mRNA type 1 collagen and
osteonectin and alkaline phosphatase activity. The expression of OAT, which is known to mediate the cellular
uptake of IS, was detected in in the MC3T3-E1 cell line. The inhibition of OAT improved cell viability and suppressed
the production of reactive oxygen species. These results suggest that IS is transported in MC3T3-E1 cells via OAT,
which causes oxidative stress to inhibit osteoblast differentiation.
Conclusions: IS acts as a bone toxin by inhibiting osteoblast differentiation and inducing apoptosis.
Keywords: Uremia, Renal osteodystrophy, Apoptosis, Cell differentiation, Organic anion transportersBackground
Indoxyl sulfate (IS) is an organic anion uremic toxin be-
longing to the family of protein-bound retention solutes
[1]. IS is synthesized in the liver from indole, which is
produced from the metabolism of dietary tryptophan in
the body. The studies performed to date have shown
that IS accumulates in blood and promotes the progres-
sion of renal dysfunction [2-5]. IS may also act as a vas-
cular toxin [2-4,6]. It directly stimulates rat vascular
smooth muscle cell proliferation in a concentration-
dependent manner. Furthermore, Dahl salt-sensitive
hypertensive rats administered IS in combination with a
high-salt diet have been found to show an increase in* Correspondence: hwgil@schmc.ac.kr
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reproduction in any medium, provided the oraortic wall thickness and severe aortic calcification, with
colocalization of osteoblast-specific proteins such as
Cbfa-1, osteonectin, and alkaline phosphatase [7]. In a
recent study, Iwasaki et al. reported that when rats with
renal dysfunction and low bone turnover were adminis-
tered an oral adsorbent, their blood IS level decreased
and osteoblastic cell function improved [8]. Iwasaki et al.
have also shown that in primary mouse calvaria osteo-
blast cell culture, addition of IS suppresses parathyroid
hormone (PTH)-stimulated intracellular cAMP produc-
tion, decreases PTH receptor expression, and induces
oxidative stress [9]. IS inhibits osteoclast differentiation
and bone-resorbing activity, which could affect bone re-
modeling in chronic kidney disease patients [10]. Lim-
ited data suggest that IS could act as a bone toxin by
affecting both osteoblast and osteoclast activities. To. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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not been fully evaluated.
Hence, we investigated whether IS acts as a bone toxin
by studying whether IS induces apoptosis and inhibits
differentiation in a cultured osteoblast cell line.
Methods
Chemicals
L-Ascorbic acid, β-glycerophosphate, probenecid, probu-
col, N-acetylcysteine (NAC), and IS were all obtained
from Sigma (St. Louis, MO, USA). All cell culture media
and supplements were from Hyclone (Logan, UT, USA).
Reagents for reverse transcription and those for real-
time PCR reactions were from Toyobo (Osaka, Japan).
Anti-Bax, Anti-Bcl-2, and anti-p53 mouse monoclonal
antibodies were purchased from Santa Cruz (Santa Cruz,
CA, USA). Secondary goat anti-rabbit IgG was obtained
from Thermo Fisher Scientific (Rockford, USA). The
assay kit for caspase-3/7 activity was purchased from
Promega (Mannheim, Germany).
Cells and osteogenic induction
Newborn mouse calvaria-derived MC3T3-E1 subclone
14 pre-osteoblastic cells (ATCC, USA) were cultured in
α-MEM medium (Hyclone) supplemented with 10% fetal
bovine serum (Hyclone), 100 U/mL penicillin, and
100 mg/mL streptomycin (Hyclone) at 37°C in an at-
mosphere with 100% humidity and 5% CO2. Osteoblast
differentiation was induced by the addition of 10 mM β-
glycerophosphate, as described previously [11].
Cell viability
Cell viability was assessed using the 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay, as described previously [12]. MC3T3-E1 cells were
incubated in osteogenic induction medium with or with-
out IS at 37°C for 72 h. After the cells were lysed with
DMSO solution, the optical density was measured at
590 nm using the optical density at 630 nm as reference
(VICTOR™X3; PerkinElmer, USA).
Bone differentiation
Alkaline phosphatase (ALP) activity was measured in
cells treated with 0–1.5 mM IS and in control cells incu-
bated for 3, 5, 7, and 10 d. Cells were washed with PBS
and were lysed with a solution containing 0.1% Triton
X-100 at the same time as the cellular alkaline phosphat-
ase activity and cell protein content were determined.
The enzymatic reaction was started by the addition of
50 μL of substrate/buffer mixture (equal volumes of p-
nitrophenol phosphate substrate [N 1891; Sigma Chemi-
cals, St. Louis, MO] and alkaline buffer solution [A9226;
Sigma Chemicals]). After 30 min of incubation at 37°C,
the reaction was stopped by adding an equal volume of0.05 M NaOH. The lysate from the wells was collected
into individual Eppendorf tubes and vortexed. The ALP
activity was determined colorimetrically at 405 nm using
p-nitrophenol (PNP) standards (0–50 nmol, N7660;
Sigma Chemicals). The protein concentration in the lys-
ate was determined using the Bradford assay. ALP activ-
ity is expressed as nanomoles of PNP released per
milligram of protein.
Assessment of cellular oxidative stress
Production of intracellular reactive oxygen species was
detected using the nonfluorescent cell-permeating com-
pound, 2′-7′-dichlorofluorescein diacetate (DCF-DA).
DCF-DA is hydrolyzed by intracellular esterases, and is
then oxidized by reactive oxygen species (ROS) to a
fluorescent compound, 2′-7′-dichlorofluorescein (DCF).
After treatment with 0–1.5 mM IS, MC3T3-E1 cells
were treated with DCF-DA (10 μM) for 30 min at 37°C.
Following DCF-DA exposure, the cells were rinsed and
then scraped into PBS with 0.2% Triton X-100. Fluores-
cence was measured with a plate reader (VICTOR™X3)
with excitation at 485 nm and emission at 535 nm.
Flow cytometry analysis of apoptosis
Quantification of cells undergoing programmed cell
death was conducted using an annexin V-propidium iod-
ide apoptosis kit (Invitrogen). Analyzed cells were
washed once in phosphate-buffered saline and resus-
pended in the binding buffer provided. Annexin V
(Alexa 488-conjugated) and propidium iodide were
added and incubated for 15 min at room temperature in
the dark. The cells were analyzed using a FACS Calibur
flow cytometer and CellQuest software.
Apoptosis measurement: caspase-3/7 activity, and
immunoblot assay for apoptosis-related factors p53,
Bcl-2, and Bax
Caspase-3/7 activity was detected using a Caspase-Glo
3/7 Assay system (Promega) after preincubating the
MC3T3-E1 cells (2 × 105/96-well plate), followed by
treatment with various IS concentrations (control,
0.5 mM, 1 mM) for 3, 6, 9, 12, and 24 h. The back-
ground luminescence associated with the cell culture
and assay reagent (blank reaction) was subtracted from
the experimental values. The activity of caspase-3/7 is
presented as the mean value of triplets for the given
cells. The intensity of the emitted fluorescence was de-
termined at a wavelength of 521 nm with the use of
luminometry (VICTOR™X3).
The immunoblot assay was conducted as follows. After
stimulation, cells were washed once with phosphate-
buffered saline and lysed with radioimmunoprecipitation
assay (RIPA) lysis buffer (ROCKLAND, USA) and placed
on ice for 30 min. Total cell extracts were centrifuged at
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pernatants were collected. Equal amounts of proteins
(40 μg) were resolved by sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis, transferred to a nitrocel-
lulose membrane, and immunoblotted with specific
antibodies against Bax, Bcl-2, and p53. Secondary anti-
bodies were obtained from Thermo Fisher Scientific.
Equal loading was confirmed using a β-actin antibody.
Protein expression levels were quantified using a densi-
tometer (ChemiDoc™ XPS + with Image Lab™ Software,
Bio-Rad). The data are represented as the ratio of ex-
pression of the target protein to that of β-actin.RNA isolation, cDNA synthesis, and PCR analysis
Total RNA was isolated using an RNeasy Mini Kit (QIA-
GEN, Tokyo, Japan) according to the manufacturer’s in-
structions. Total RNA (1 μg) was used as the template for
cDNA synthesis in a 50-μL reaction mixture using a reverse
transcriptase-PCR kit (TOYOBO) according to the manu-
facturer’s instructions. Real-time PCR was performed on a
CFX96™ (BIO-RAD). The PCR reactions consisted of
Power SYBR Green PCR Master Mix (Applied Biosystems,
UK), 0.1 mM (10 pM) specific primers, and 50 ng of cDNA.
The primer sequences, designed with Beacon Designer 7.6
software (Bio-Rad), were as follows: mouse osteonectin, 5′-
TCTCAACAAACAAATCAGGGAT-3′ and 5′-TGGCAG-
CACATTCATCTATG-3′; collagen 1, 5′-ATCACCAAACT
CAGAAGATGTAG-3′ and 5′-CAGGAAGTCCAGGCTG
TC-3′; organic anion transport 1 (OAT1), 5-ATG CCT
ATC CAC ACC CGT GC-3 and 5-GGC AAA GCT AGT
GGC AAA CC-3); OAT3, 5-CAG TCT TCA TGG CAG
GTATAC TGG-3 and 5-CTG TAG CCA GCG CCA CTG
AG-3; and GAPDH, 5′-CAAGAAGGTGGTGAAGCA-3′
and 5′-TGTTGAAGTCGCAGGAGA-3′.Figure 1 Effect of IS on the viability of MC3T3-E1 cells. Cell number w
from 0.1 to 1.5 mM and was expressed as the percentage of control cells n
dose dependent. The data represent the mean ± SEM from 8 replicates in eStatistical analysis
All results are expressed as the mean ± standard error of
the mean (SEM) values. The mean values of the groups
were compared by analysis of variance, and a P-value
<0.05 was considered significant.Results
Effect of indoxyl sulfate on cell viability in the MC3T3-E1
cell line
To determine cytotoxicity, the effect of IS on the cell
proliferation of MC3E3-T1 was studied using an MTT
assay. As shown in Figure 1, IS, at the concentration
range of 0.1–1.5 mM, inhibited cell proliferation at 72 h.Gene expression of OATs in the MC3T3-E1 cell line
Because other studies have shown that IS is transported
into osteoblasts and renal tubule cells via OAT, gene ex-
pression of OAT-1 and OAT-3 was investigated by real
time PCR using RNA extracts. The expression of OAT-3
was relatively higher than that of OAT-1 in the MC3T3-E1
cell line (Figure 2A). After confirming the expression of the
OAT gene in the MC3T3-E1 cell line, we investigated
whether blocking OAT could prevent IS toxicity. To con-
firm the role of OAT in MC3T3-E1 cells, probenecid, a
transporter inhibitor, was added to the cells during pretreat-
ment with 1 mmol/L of IS. Blocking OAT in MC3T3-E1
cells improved cell survival (Figure 2B). ROS production
was inhibited by probenecid. The effect obtained was simi-
lar to that obtained on pretreatment with the antioxidants
NAC (500 μM) and probucol (62.5 μM) (Figure 2C).
Probenecid works by interfering with the OAT in the kid-
neys, which blocks the efflux of IS in cells. Probucol is a
phenolic lipid-lowering agent with antioxidant and anti-
inflammatory properties. N-acetylcysteine (NAC) is theas measured 24 h after the addition of IS at concentrations ranging
ot pretreated with IS (open bar). The cell toxicity of IS was found to be
ach group. *P < 0.05 vs. control cells.
Figure 2 Expression of the OAT gene in MC3T3-E1. (A) OAT gene expression was determined by real time-polymerase chain reaction using
RNA extracts. The expression of OAT-3 was relatively higher than that of OAT-1. The data represent the mean ± SEM (n = 3 for each group).
(B) Probenecid (20 mM), an OAT inhibitor, reduced IS-induced cell toxicity, which is similar to an antioxidant effect. OAT is an IS transporter in
MC3T3-E1 cells. The data represent the mean ± SEM from six determinations in each group. (C) IS-induced free radical production was suppressed
by probenecid and antioxidants. The data represent the mean from six replicates in each group. OAT, organic anion transport; IS: indoxyl sulfate.
*P < 0.05 vs control, ** P < 0.05 vs IS.
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one and has been widely used as an antioxidant.
Intracellular oxidative stress
As shown in Figure 3, IS increased cellular oxidative
stress in a concentration-dependent manner. Addition
of antioxidants or the OAT inhibitor suppressed free
radical production (Figure 2C, Figure 3).
Inhibition of osteoblast differentiation by IS
To determine the differentiation of the pre-osteoblast
cell line, ALP activity was measured in osteogenic induc-
tion medium with or without IS. As shown in Figure 4,
ALP activity was suppressed above 1 mM IS. Collagen 1
and osteonectin were produced only in differentiated
osteoblasts. To determine whether the osteoblasts
had differentiated, the expression of collagen 1 andosteonectin mRNA was analyzed using real-time
PCR. At 5 d, the production of collagen 1 and osteo-
nectin mRNA was significantly inhibited by the
addition of IS, as shown in Figure 5.Apoptosis induction by IS
To determine whether IS induces apoptosis, the cells
were incubated with different concentrations of IS for
12 h, stained, and subjected to Fluorescence-activated
cell sorting (FACS) analysis to measure apoptosis and
necrosis. IS increased the proportion of apoptotic cells,
particularly in osteoblasts (Figure 6). To elucidate the
role of caspases in osteoblasts, we first examined the ac-
tivity of the executioner caspase-3/7 in response to IS in
osteoblasts. The activity of caspases was determined
using fluorometric peptide substrates specific to caspase.
As shown in Figure 7, the activity of caspase-3/7 peaked
Figure 3 Free radical production induced by the addition of IS. MC3T3-E1 cells were seeded in 96-well plates, IS was added, and free radical
production was measured after the indicated time. (A) Free radical production increased with time in a dose-dependent manner. (B) IS-induced
free radical production was suppressed by 0.5 mM N-acetylcysteine (NAC). The data represent the mean from six replicates ns in each group.
Kim et al. BMC Pharmacology and Toxicology 2013, 14:60 Page 5 of 9
http://www.biomedcentral.com/2050-6511/14/60at 6 h of incubation with IS (1.0 mM). Caspase-
dependent apoptosis thus appears to be involved in IS-
induced osteoblast toxicity. To determine which
apoptosis-related factors may be acting upstream of cas-
pase activation, the expression of p53, Bcl2, and Bax was
measured after the addition of IS (1.0 mM). IS increased
the expression of Bax and p53, which play a role inFigure 4 Effect of IS addition on ALP activity in MC3T3-E1 cells. ALP a
activity is expressed as nanomoles of p-nitrophenol released per milligram
time point. The data represent the mean ± SEM (n = 6 for each group).apoptosis. However, Bcl-2 was not influenced by IS
(1.0 mM) at 1, 3, and 6 h (Figure 8).
Discussion
In the present study, we studied whether the uremic
toxin IS directly suppressed osteoblast differentiation
and induced osteoblast apoptosis via caspase activity.ctivity was suppressed by IS at concentrations greater than 1 mM. ALP
of protein. ALP, alkaline phosphatase *P < 0.05 vs. control cells at each
Figure 5 Changes in collagen 1 and osteonectin gene expression in MC3T3-E1 cells after IS addition. (A) Expression of the osteonectin
gene upon treatment with various concentrations of IS at 5 d. (B) Expression of the collagen 1 gene upon treatment with various concentrations
of IS at 5 d. *P < 0.05 vs. control cells. The data represent the mean ± SEM (n = 4 for each group).
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duction, which evokes apoptosis. Our data emphasize
the fact that several uremic toxins could affect osteoblast
differentiation and function. Recently, several reports
have shown that IS may be a bone toxin [8-10]. Iwasaki
et al. [8] showed that oral administration of the indole-
absorbing Kremezin prevents the progression of renal
failure and improves bone formation in a rat model of
chronic kidney disease (CKD) with low bone turnover.Figure 6 Effect of IS on MC3-T3 cell apoptosis, determined by FACS a
24 h, after which they were harvested, the DNA was stained with propidium
proportion of apoptotic cells in MC3-T3 cells. *P < 0.05 vs. control cells. TheThis group also demonstrated that the IS taken up by
osteoblasts via the OAT-3 present in these cells aug-
ments oxidative stress to impair osteoblast function and
downregulate PTH receptor expression [9]. These find-
ings suggested that IS may be a bone toxin that is taken
up via OAT-3 in osteoblasts and inhibits bone turnover
by free radicals produced because of IS. Our data sup-
port the previous studies and suggest that IS itself could
induce apoptosis via the production of free radicals.nalysis. (A) Cells were incubated with various concentrations of IS for
iodide, and the cells were analyzed using FACS. (B) IS increased the
data represent the mean ± SEM (n = 3 for each group).
Figure 7 Effect of IS on caspase-3/7 activity. Caspase-3/7 activity was analyzed using a Promega Caspase Glo 3/7 kit (described in the Materials
and Methods) Caspase-3/7 activity peaked at 6 h at 1 mM IS. IS increased caspase- 3/7 activity, but probenecid (20 mM), an OAT inhibitor, attenu-
ated IS- induced caspase-3/7 activity, which is similar to an antioxidant effect. The data represent the mean ± SEM (n = 6 for each group).
*P < 0.05 vs. control cells at each time point.
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ated by caspases. It is well established that p53 positively
regulates Bax, but negatively regulates Bcl-2 expression
[13]. IS-elicited changes in the Bax protein level are
likely to be the result of an increase in p53 [14]. The
Bcl-2 family plays a prominent antiapoptotic role by act-
ing upstream of caspase activation. Our data showed
that the expression of Bcl-2 is not influenced at 1, 3, or
6 h. The proapoptotic factors Bax and p53 may play a
predominant role in IS-induced osteoblast apoptosis,
which is activated via the caspase pathway.
Mozar et al. showed that IS inhibits osteoclast differ-
entiation and bone-resorbing activity [10]. Goto et al.
[15] reported that IS levels correlated negatively with 2Figure 8 Effect of IS on the protein expression of Bcl-2, Bax, and p53
anti-Bax, anti-p53, and anti-β-actin at 1 mM IS. (B) Densitometric analysis o
represent the mean ± SEM (n = 3 for each group).serum markers of bone formation (alkaline phosphatase
and bone-specific alkaline phosphatase) independently
of intact PTH, but not with a serum marker of bone re-
sorption (TRAP 5b). Although serum markers may not
be ideal for testing bone turnover, on the basis of their
results, they suggested that IS may promote low-turn-
over bone disease outcomes (such as adynamic bone dis-
ease) observed in CKD patients.
With CKD progression, the ability of the kidneys to
maintain systemic mineral homeostasis gradually de-
creases, resulting in the various abnormalities of
bone and vascular physiology observed in CKD-MBD
(CKD associated with mineral and bone disorders)
[16]. In high-turnover bone disease, e.g., secondaryin MC3-T3 cells. (A) Representative immunoblots with anti-Bcl-2,
f Bcl-2, Bax, and p53, normalized by the data for β-actin. The data
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controlled by many drugs, including phosphate
binders, vitamin D, and cinacalcet. However, no
treatment specific to low-turnover bone disease is
available. Elimination of uremic toxins could be an
option for controlling low-turnover bone disease in
CKD patients.
Our study suggested that IS-induced apoptosis
might be mediated by free radical production. These
findings are supported by many previous reports
[15,16]. Several studies have shown that IS induces
NADPH oxidase mRNA expression and increases its
activity in various types of cells [17-19]. Namikoshi
et al. reported that decreasing the serum concentra-
tion of IS by administrating the oral adsorbent AST-
120 reduces the expression of the NADPH oxidase
component and alleviates oxidative stress in the aorta
[20]. In our study, we did not determine NADPH
mRNA expression or its activity, but it appears that
increasing free radical production by adding IS may occur
through an activation pathway of NADPH oxidase.
A list of uremic toxins has been provided by
EUTox. The normal concentration of IS is 0.53 mg/L
(2 μM). The mean concentration of IS in uremic patients
is 23.1 mg/L (~100 μM), and the maximum concentration
found in uremic patients was 44.5 mg/L [21].
Conclusions
Our data confirm that IS acts as a bone toxin by inhibit-
ing osteoblast differentiation and inducing apoptosis via
the caspase pathway. Further studies are required to elu-
cidate whether elimination of IS could improve osteo-
blast differentiation in chronic renal failure.
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